Comparing Efficacy & Safety Of TNX-1300 To Placebo With UC For Treatment Of Acute Cocaine Intoxication In ED Subjects (CATALYST)
Trial details
- Registry ID
- NCT06045793
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as Cocaine esterase
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Comparing Efficacy & Safety Of TNX-1300 To Placebo With UC For Treatment Of Acute Cocaine Intoxication In ED Subjects (CATALYST)NCT06045793 | Tonix Pharmaceuticals, Inc. | Phase 2 | Terminated | 2025-04-21Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |